Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06942351 · ClinicalTrials.gov registry record · NA

Effect of Walnuts on Cognitive Function and Gut Microbiome in Older Adults

A NA study of Aging and Inflammation Biomarkers, sponsored by Oregon State University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06942351 is a NA study of Aging and Inflammation Biomarkers that is actively recruiting participants, run by Oregon State University. The registered enrollment target is 80 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06942351, a NA study of Aging and Inflammation Biomarkers, is actively recruiting participants, sponsored by Oregon State University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the impact of daily consumption of walnuts for 12 weeks on cognitive function, markers of inflammation and oxidative stress, and the gut microbiome in healthy adults age 55 years and older.

Interventions

  • OTHER Walnuts
  • OTHER Crackers

Study Locations (1)

Oregon

  • Oregon State University - Corvallis

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-06-09
Est. Completion 2029-05
Phase NA

Sponsor

Oregon State University

33 total trials

What the Registry Record Tells You About NCT06942351

The ClinicalTrials.gov registry entry for NCT06942351 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The listed sponsor is Oregon State University, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Walnuts is the first listed.

NCT06942351 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT06942351 about?

NCT06942351 is a clinical study titled "Effect of Walnuts on Cognitive Function and Gut Microbiome in Older Adults". The purpose of this study is to examine the impact of daily consumption of walnuts for 12 weeks on cognitive function, markers of inflammation and oxidative stress, and the gut microbiome in healthy adults age 55 years and older.

What is the current status of trial NCT06942351?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-06-09. Estimated completion is 2029-05.

What conditions does trial NCT06942351 study?

This clinical trial studies the following conditions: Aging, Inflammation Biomarkers.

What interventions are being tested in trial NCT06942351?

The interventions under investigation include: Walnuts (OTHER), Crackers (OTHER).

Who is sponsoring clinical trial NCT06942351?

This trial is sponsored by Oregon State University, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06942351 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.